Beximco Pharmaceuticals Limited
Beximco Pharmaceuticals Limited (LSE: BXP) is trading at £0.53, about ₹67 at today's GBP/INR rate, as of 30 Sep 2026, 4:39 AM ET, down 3.32% today. Indian residents can buy Beximco Pharmaceuticals from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
£0.53
Today's high
£0.54
52 week low
£0.00
52 week high
£0.65
BXP opened at £0.54, closed previously at £0.55, and has traded between £0.00 and £0.65 over the past 52 weeks.
About
Established in 1976 and headquartered in Dhaka, Bangladesh, Beximco Pharmaceuticals Limited is a prominent company engaged in the production and distribution of generic pharmaceutical formulations and active pharmaceutical ingredients (APIs). The firm’s extensive product line addresses a wide range of therapeutic areas, including treatments for allergic disorders, pain and fever, various infections (antibacterial and antiviral), cardiovascular conditions, central nervous system ailments, respiratory illnesses, endocrine disorders, diabetes, gastrointestinal problems, hormonal therapies, oncology, musculoskeletal issues, and skin conditions. Its offerings also encompass eye care products, vitamin and mineral supplements, and intravenous fluids. These medications are supplied in a comprehensive array of dosage forms, such as solids, liquids, creams, ointments, suppositories, metered-dose and dry powder inhalers, nasal sprays, sterile injectables (including lyophilized forms), and large volume intravenous fluids. Beyond its own diverse portfolio, Beximco Pharmaceuticals provides contract manufacturing services to other companies and actively exports its products internationally.
Key statistics
Avg. volume
60.95K
Market cap
£235.05M
P/E Ratio
4.50
Price-to-sales ratio
0.72
Enterprise value
BDT 30.67B
Free cash flow yield
15.30%
Debt-to-equity ratio
0.05
Return on equity
13.07%
ROIC
11.20%
Beta
0.25
Dividend yield
4.40%
Last dividend
£0.02
Financial overview
Revenue
BDT 49.12B
Earnings per share
BDT 15.56
Free cash flow
BDT 4.19B
Net profit margin
16.04%
Gross margin
45.47%
EBITDA
BDT 11.99B
Revenue growth
10.65%
Similar securities
This is not an investment recommendation
How to buy Beximco Pharmaceuticals from India
Indian residents can buy Beximco Pharmaceuticals shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to GBP.
Search for Beximco Pharmaceuticals and place an order
Find Beximco Pharmaceuticals by name or by its ticker, BXP, and choose an order type. Beximco Pharmaceuticals trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Beximco Pharmaceuticals position in GBP and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Beximco Pharmaceuticals from India
Trading and taxes when buying Beximco Pharmaceuticals from India
Trading and limits
- Trading hours
- 8:00 am – 4:30 pm UK
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Beximco Pharmaceuticals’ current yield is 4.40%.Dividend tax explained
- Transaction tax
- The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it.
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Beximco Pharmaceuticals stock?
Yes. Beximco Pharmaceuticals (BXP) has been listed on the London Stock Exchange since 2005, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to GBP. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Beximco Pharmaceuticals share cost in rupees?
One Beximco Pharmaceuticals share is £0.53 — about ₹67 at a GBP/INR rate of 127.06 on 29 Sep 2026. Both the Beximco Pharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Beximco Pharmaceuticals from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on Beximco Pharmaceuticals shares taxed in India?
Non-residents are exempt from UK capital gains tax on the disposal of listed shares, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the GBP/INR rate on the purchase and the sale date, so the rupee move counts alongside the Beximco Pharmaceuticals price. Paasa issues a capital-gains statement for your return.
Does Beximco Pharmaceuticals pay a dividend, and how is it taxed in India?
Yes. Beximco Pharmaceuticals pays a dividend and the current yield is 4.40%; the last declared dividend was £0.02 per share, about ₹2.95. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Beximco Pharmaceuticals from India?
The London Stock Exchange trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when the UK is on standard time. Orders can only execute during that window.
Is Beximco Pharmaceuticals a United Kingdom company, and does that change how it is taxed?
Beximco Pharmaceuticals trades on the London Stock Exchange in GBP, but the company is domiciled in Bangladesh. Beximco Pharmaceuticals trades as an ordinary share listed directly in the UK, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Are there transaction taxes when buying Beximco Pharmaceuticals?
The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it. This is charged by the market, not by Paasa.
Do I have to declare Beximco Pharmaceuticals shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Beximco Pharmaceuticals holding, its cost and its closing value.
How do I sell Beximco Pharmaceuticals and bring the money back to India?
You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in GBP in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.